Researcher at University of Oslo Publishes New Study Findings on Multiple Myeloma (Vaccinating Against Mutated RAS in Multiple Myeloma: The Phase I/II TG01/QS-21 Study)

MLA

“Researcher at University of Oslo Publishes New Study Findings on Multiple Myeloma (Vaccinating Against Mutated RAS in Multiple Myeloma: The Phase I/II TG01/QS-21 Study).” Vaccine Weekly, 25 Dec. 2024, p. 88. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.820845710&authtype=sso&custid=ns315887.

APA

Researcher at University of Oslo Publishes New Study Findings on Multiple Myeloma (Vaccinating Against Mutated RAS in Multiple Myeloma: The Phase I/II TG01/QS-21 Study). (2024, December 25). Vaccine Weekly, 88.

Chicago

Vaccine Weekly. 2024. “Researcher at University of Oslo Publishes New Study Findings on Multiple Myeloma (Vaccinating Against Mutated RAS in Multiple Myeloma: The Phase I/II TG01/QS-21 Study),” December 25. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.820845710&authtype=sso&custid=ns315887.